Science Committee

Science Committee is responsible for the oversight, development, review, funding and management of a portfolio of basic and translational cancer research Programme and Project Awards. The Science Committee meets twice a year, in April and October.

Research areas

The Science Committee has a broad remit spanning basic and translational cancer research, responsible for a number of funding schemes including: Programme Awards and career stage funding which cover the entire remit, and; project awards in specific research areas.

Funding schemes

Programme Awards

Science Committee Programme Awards provide long-term support for broad, multidisciplinary research where the aim is to answer an interrelated set of questions. Applications for Programme Awards will be accepted in any of the following research areas:

  • Basic biological research relating to cancer
  • Preclinical studies that will generate biological data to underpin therapeutic development
  • Biomarker research
  • Imaging research
  • Radiotherapy research
  • The application of engineering and physical sciences to cancer

Programme Foundation Awards

Programme Foundation Awards allow excellent researchers with between eight and fourteen years’ post-PhD experience to establish or further develop their independent research group.  On completion of a Programme Foundation Award we expect researchers to be in a competitive position to apply for a Science Committee Programme Award.  Applications will be accepted within the same scientific remit as Programme Awards.

Cancer Immunology Project Awards

Cancer Immunology Project Awards seek to catalyse research and build the UK’s research base in cancer immunology, by funding immunologists in non-cancer fields to apply ground-breaking research in a cancer context.

Multidisciplinary project Award

The Multidisciplinary Project Award supports collaborations between clinical and non-clinical cancer researchers, and scientists from engineering/physical science disciplines, where the aim is to generate creative research ideas and explore their applicability in cancer research.

How proposals are judged

The Committee meets twice a year in April and October, and assesses all applications on the basis of their scientific and strategic importance, whilst also studying expert peer review collated for each grant. Applications are judged on the basis of scientific excellence, innovation and relevance to cancer research.

 

Chair of the Science Committee

Professor Adrian Hayday – The Francis Crick Institute & King’s College London

Vice Chair of the Science Committee

Professor Tony Green – University of Cambridge

Members of the Science Committee

Professor Geneviève Almouzni – Institute Curie, Paris

Professor Mark Arends – University of Edinburgh

Professor Sir Michael Brady – University of Oxford

Professor Kevin Brindle – University of Cambridge

Professor Tim Elliott – University of Southampton

Professor Tariq Enver – University College London

Professor Gerard Evan – University of Cambridge

Professor Duncan Graham – University of Strathclyde

Professor Tony Green – University of Cambridge

Professor Adrian Hayday – The Francis Crick Institute & King’s College London

Professor Manuel Hidalgo – CNIO, Madrid

Professor Daniel Hochhauser – University College London

Professor Clare Isacke – The Institute of Cancer Research, London

Professor Josef Jiricny – University of Zurich

Dr Jan Korbel – EMBL, Heidelberg

Professor Ruth Plummer – University of Newcastle

Dr Steven Pollard – University of Edinburgh

Dr Erik Sahai – The Francis Crick Institute

Professor Charles Swanton – The Francis Crick Institute & University College London

Professor Katherine Vallis – CRUK Oxford Institute

Chair of the Cancer Immunology Review Panel

Professor Tim Elliott – University of Southampton

Vice Chair of the Cancer Immunology Review Panel

Professor Adrian Hayday – The Francis Crick Institute & King’s College London

Members of the Cancer Immunology Review Panel

Professor Judi Allen – University of Edinburgh

Professor Vincenzo Cerundolo – University of Oxford

Professor David Gray – University of Edinburgh

Professor Gillian Griffiths – University of Cambridge

Professor George Kassiotis – The Francis Crick Institute

Professor Paul Martin – University of Bristol

Professor Hans Stauss – University College London

Professor Paresh Vyas – Weatherall Institute for Molecular Medicine.

Chair of the Multidisciplinary Review Panel

Professor Sir Mike Brady — University of Oxford

Vice Chair of the Multidisciplinary Review Panel

Professor Duncan Graham — University of Strathclyde

Members of the Multidisciplinary Review Panel

Professor Tom Brown — University of Oxford

Professor Mark Chaplain — University of St Andrews

Professor Steven Clifford — University of Newcastle

Dr Matthew Fuchter — Imperial College London

Professor Eyal Gottlieb — CRUK Beatson Institute

Professor Uwe Oelfke — The Institute of Cancer Research, London

Professor Erik Sahai — The Francis Crick Institute

Professor Chris Schofield — University of Oxford

Professor Ben Simons — University of Cambridge

Professor Joachim Spatz — Max Planck, Stuttgart

Contact for this committee

gemma balmerDr Gemma Balmer

Senior Research Funding Manager

gemma.balmer@cancer.org.uk

Tel: 020 3469 6125

Professor of biochemistry - Gerard Evan

Gerard is an established independent researcher in basic and translational research who is funded by our Science Committee.

Share this page